tiprankstipranks
CanSino Biologics, Inc. Class H (HK:6185)
:6185

CanSino Biologics, Inc. Class H (6185) Revenue

5 Followers

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 369.80M in the quarter ending Dec 31, 2025, with 19.24%. This bring the company's revenue in the last twelve months to 1.06B, Decreased 9.32%. In the fiscal year ending Dec 31, 2025, CanSino Biologics, Inc. Class H had annual revenue of 1.03B with 21.93% growth.
Revenue (ttm)
1.06B
Revenue Growth
29.21%
P/S Ratio
13.06
Revenue/Employee
HK$933,914
Employees
1,105
Market Cap
HK$13.47B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
1.03B185.64M+21.93%
Dec 31, 2024
846.34M501.16M+145.19%
Dec 31, 2023
345.18M-685.86M-66.52%
Dec 31, 2022
1.03B-3.27B-76.02%
Dec 31, 2021
4.30B4.27B+17,174.82%
Dec 31, 2020
24.89M22.61M+990.05%
Dec 31, 2019
2.28M1.15M+101.71%
Dec 31, 2018
1.13M-8.05M-87.67%
Dec 31, 2017
9.18M